In studies on breast cancer patients, for example, we recently showed that increases in urinary IL-6 concentrations preceded fatigue decreases by 48–60 h (31) and that increased levels of urinary neopterin preceded fatigue increases by 24 h (32) and 60–72 h (33). This evidence concerns the gene IL6 and breast carcinoma.